These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19544453)

  • 41. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
    Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
    Wakimoto H; Kesari S; Farrell CJ; Curry WT; Zaupa C; Aghi M; Kuroda T; Stemmer-Rachamimov A; Shah K; Liu TC; Jeyaretna DS; Debasitis J; Pruszak J; Martuza RL; Rabkin SD
    Cancer Res; 2009 Apr; 69(8):3472-81. PubMed ID: 19351838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity.
    Rasper M; Schäfer A; Piontek G; Teufel J; Brockhoff G; Ringel F; Heindl S; Zimmer C; Schlegel J
    Neuro Oncol; 2010 Oct; 12(10):1024-33. PubMed ID: 20627895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.
    Moutal A; Honnorat J; Massoma P; Désormeaux P; Bertrand C; Malleval C; Watrin C; Chounlamountri N; Mayeur ME; Besançon R; Naudet N; Magadoux L; Khanna R; Ducray F; Meyronet D; Thomasset N
    Cancer Res; 2015 Sep; 75(17):3519-28. PubMed ID: 26122847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
    Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
    Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma.
    Chen G; Kong J; Tucker-Burden C; Anand M; Rong Y; Rahman F; Moreno CS; Van Meir EG; Hadjipanayis CG; Brat DJ
    Cancer Res; 2014 Aug; 74(16):4536-48. PubMed ID: 24947043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
    Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
    Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
    Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
    Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
    Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
    BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
    Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
    Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.